Project for Multi-Omics-Based Early Detection of Hepatocellular Carcinoma (PROMETHEA Study)
City of Hope Medical Center · NCT07265271
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 600
- US sites recruiting
- 1
- Study start
- January 15, 2025
- Record last updated
- July 1, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Hepatocellular carcinoma (HCC) is often diagnosed at an advanced stage, and early detection is critical for improving patient outcomes. Despite this, reliable non-invasive biomarkers for early-stage HCC are limited.
This study seeks to develop a multi-omics-based liquid biopsy assay, especially focusing on ncRNAs (e.g. tsRNA, miRNA, circRNA, lncRNA, etc.) for accurate detection of early-stage HCC.
Being studied: Small RNA sequence; Rt-qPCR; Rt-qPCR
Conditions: Hepatocellular Carcinoma (HCC)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adults aged 18 to 100 years.
- A histologically confirmed diagnosis of hepatocellular carcinoma.
- A clinically diagnosed as chronic liver disease, including chronic hepatitis or liver cirrhosis, without evidence of hepatocellular carcinoma.
- Healthy volunteers without known liver disease or malignancy.
- Received standard diagnostic and staging procedures as per local guidelines
- Availability of blood or other biospecimens.
- Ability to provide written informed consent.
Exclusion Criteria
- Lack of or inability to provide informed consent
- History of other active malignancies within the past 5 years
- Previous liver transplantation
- Severe systemic infection or inflammatory disease at the time of enrollment
- Inadequate sample quality or quantity
Recruiting US locations
City of Hope Medical Center
Duarte, CA 91016
Site contact: Ajay Goel, PhD · 626-218-3452 · ajgoel@coh.org
Study contacts (from the official record)
- Goel Ajay, PhD · 626-218-3452 · ajgoel@coh.org
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55